top of page
Overview

Overview

B and M logo.jpg
aron.png

COVID-19 Health Declaration

INTRODUCTION

Welcome to the COVID declaration for B&M Extra Ordinary Regional Christmas Briefing 2020 declaration. As part of B&M's event planning and to ensure a safe event for all attending, we have engaged in a risk assessment process, looking at possible control measures for the event, travel and adopting current government guidance and requirements.

​

Part of the entry requirements for the event is that a health declaration is completed by all delegates, staff, or third parties working on the event. This declaration seeks to confirm employees/delegates or anyone in their household are not showing any symptoms of COVID-19 before they are permitted access into the venue. 

​

​

​

ABOUT THE DECLARATION

This declaration will outline key symptoms of COVID-19 and ask you to confirm you are not showing any of these, nor anyone in your household. In addition, if you are classed as a clinically extremely vulnerable person you should declare this in the relevant question. If you are unsure, please click here

The form will also ask you to confirm that you agree to your details being submitted and held by this system. 

​

Your details are held securely for the purpose of the health declaration only. Your details will not be shared with anyone outside of your employer or ESS. 

​

Once confirmation is provided to your employer, all details are removed from the system. If you have any concerns, please contact either your employer directly or our office info@ess-consultants.co.uk. To continue with the declaration, please select the button below. 

​

​

​

Clinically VPs

CLINICALLY EXTREMELY VULNERABLE PEOPLE

Clinically extremely vulnerable people may include the following people. Disease severity, history or treatment levels will also affect who is in this group.

  1. Solid organ transplant recipients.

  2. People with specific cancers:

    • people with cancer who are undergoing active chemotherapy

    • people with lung cancer who are undergoing radical radiotherapy

    • people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment

    • people having immunotherapy or other continuing antibody treatments for cancer

    • people having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors

    • people who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs

  3. People with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary (COPD).

  4. People with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell).

  5. People on immunosuppression therapies sufficient to significantly increase risk of infection.

  6. Women who are pregnant with significant heart disease, congenital or acquired.

People in this group should have been contacted to tell them they are clinically extremely vulnerable.

If you are still concerned, you should discuss your concerns with your GP or hospital clinician.

bottom of page